95 related articles for article (PubMed ID: 17675525)
1. Fully MHC-disparate mixed hemopoietic chimeras show specific defects in the control of chronic viral infections.
Koehn BH; Williams MA; Borom K; Gangappa S; Pearson TC; Ahmed R; Larsen CP
J Immunol; 2007 Aug; 179(4):2616-26. PubMed ID: 17675525
[TBL] [Abstract][Full Text] [Related]
2. Primary and secondary immunocompetence in mixed allogeneic chimeras.
Williams MA; Adams AB; Walsh MB; Shirasugi N; Onami TM; Pearson TC; Ahmed R; Larsen CP
J Immunol; 2003 Mar; 170(5):2382-9. PubMed ID: 12594261
[TBL] [Abstract][Full Text] [Related]
3. Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation.
Kyburz D; Speiser DE
Transpl Immunol; 1995 Jun; 3(2):143-50. PubMed ID: 7582905
[TBL] [Abstract][Full Text] [Related]
4. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
5. Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells.
Hunziker L; Klenerman P; Zinkernagel RM; Ehl S
Eur J Immunol; 2002 Feb; 32(2):374-82. PubMed ID: 11813156
[TBL] [Abstract][Full Text] [Related]
6. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope.
Gegin C; Lehmann-Grube F
J Immunol; 1992 Nov; 149(10):3331-8. PubMed ID: 1385522
[TBL] [Abstract][Full Text] [Related]
7. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
8. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
9. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
10. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
[TBL] [Abstract][Full Text] [Related]
11. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
Rall GF; Mucke L; Oldstone MB
J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
[TBL] [Abstract][Full Text] [Related]
12. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
13. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice.
Moskophidis D; Lechner F; Hengartner H; Zinkernagel RM
J Immunol; 1994 May; 152(10):4976-83. PubMed ID: 8176216
[TBL] [Abstract][Full Text] [Related]
14. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen.
Williams MA; Onami TM; Adams AB; Durham MM; Pearson TC; Ahmed R; Larsen CP
J Immunol; 2002 Nov; 169(10):5387-91. PubMed ID: 12421910
[TBL] [Abstract][Full Text] [Related]
16. Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection.
Doherty PC; Allan JE
Eur J Immunol; 1986 Oct; 16(10):1237-42. PubMed ID: 3490385
[TBL] [Abstract][Full Text] [Related]
17. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent.
Zinkernagel RM; Sado T; Althage A; Kamisaku H
Eur J Immunol; 1984 Jan; 14(1):14-23. PubMed ID: 6198181
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
19. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
[TBL] [Abstract][Full Text] [Related]
20. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
